COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 32: Articles 311-320  | Next

Independent Validation of Test-Adjusted COVID-19 Incidence Estimates Using Wastewater Surveillance Data in Ontario, Canada
Fisman, D., Wilson, N., Lee, C. E., Tuite, A.
10.64898/2026.05.08.26352754 — Posted: 2026-05-12
Monocyte Oxidative Stress Underlies Persistent Immune Activation in Long-COVID Postural Orthostatic Tachycardia Syndrome
Mohamed, M. A., Golchha, M., Vance, Y. A., Paranjape, S. Y., Wanjalla, C., Hunter, K. C., Dikalov, S., Diedrich, A., Kulapatana, S., Mehr, P. E., Solis Montegegro, T. X., Simmons, J. D., Harrison, D. G., Shibao, C. A.
10.64898/2026.05.08.26352776 — Posted: 2026-05-12
AI-discovered protein fragments as generalizable regulators of biomolecular condensates
Savinov, A., Sadasivan, J., White, K. J., Rubien, J. D., Li, G.-W., Case, L. B.
10.64898/2026.05.08.723928 — Posted: 2026-05-12
Crude Fucus vesiculosus fucoidan demonstrates superior SARS-CoV-2 antiviral activity compared to its pure form: binding kinetics and functional studies
Dudek, A., Janapatla, R. P., Chen, C. L., Chiu, C. H.
10.64898/2026.05.07.723385 — Posted: 2026-05-12
Temperature-Dependent Replication and Sensitivity to Innate Immunity of Human Coronavirus HKU1
Buchrieser, J., Thuillier, E., Postal, J., Wileveau, A., Guivel-Benhassine, F., Staropoli, I., Saunders, N., Planas, D., Sugrue, J., Bondet, V., Fernandez, I., Bontems, F., Porrot, F., Petiot, C., Prot, M., Jungbauer-Groznica, M., Arowas, L., Michel, V., Blanc, C., Trouillet-Assant, S., Bruel, T., Rey, F. A., Rameix-Welti, M.-A., Casartelli, N., Fontanet, A., White, M., Duffy, D., Simon-Loriere, E., Schwartz, O.
10.64898/2026.05.07.723210 — Posted: 2026-05-12
SARS CoV 2 Associated Shifts in the Upper Respiratory Tract Mycobiome in Non Hospitalized Cases
Tomar, S. S., Khairnar, K.
10.64898/2026.05.07.26352639 — Posted: 2026-05-10
Delayed humoral kinetics but stabilization of IgG responses in common variable immunodeficiency after SARS-CoV-2 mRNA booster vaccination
Federico, L., Loeken, R. O., Quy, K. L., Osen, J. R., Chaban, V., Nordoey, I., Skarpengland, T., Lundin, K. E., Fjellgaard Joergensen, S., Fraz, M. S. A., Aukrust, P., Lund, K. P., Tran, T. T., Nygaard Osnes, L. T., Lund-Johansen, F., Kared, H., Fevang, B., Munthe, L. A.
10.64898/2026.05.07.26352649 — Posted: 2026-05-08
Positive Registration Rate as a Key Determinant of COCOA Effectiveness: Empirical Evidence from Individual-Level Key-Match Data during the Sixth and Seventh COVID-19 Waves in Japan
Nakagawa, S., Kumagai, S., Yamamoto, A.
10.64898/2026.05.06.26352506 — Posted: 2026-05-08
Safety first: should the high tolerability of intramuscular anti-spike COVID-19 monoclonal antibody change our expectations of vaccine safety?
Putrino, D., Curtis, A., Leston, M., Yalcin, I., Gerlach, R., Elia, M., Mina, M.
10.64898/2026.05.08.26352596 — Posted: 2026-05-08
The Effect of Vaccination on the Evolution of the SARS-CoV-2 B.1.351 Variant
Wang, Z., Raeihle, M., Braun-Gorman, S., Leung, I., Richards, C., Gabbay, L., Shamoon-Pour, M.
10.64898/2026.05.06.723356 — Posted: 2026-05-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).